LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Affordable Coagulation Analyzers Provide Broad Testing Range

By LabMedica International staff writers
Posted on 27 Jan 2015
Print article
Image: The single-channel ERBA ECL 105 – one of two new coagulation analyzers from Transasia that provide users with freedom of testing choice from a broad range of tests and patients with dependable, timely results (Photos courtesy of Transasia Bio-Medicals).
Image: The single-channel ERBA ECL 105 – one of two new coagulation analyzers from Transasia that provide users with freedom of testing choice from a broad range of tests and patients with dependable, timely results (Photos courtesy of Transasia Bio-Medicals).
Image: The four-channel ERBA ECL 412 – one of two new coagulation analyzers from Transasia that provide users with freedom of testing choice from a broad range of tests and patients with dependable, timely results (Photos courtesy of Transasia Bio-Medicals).
Image: The four-channel ERBA ECL 412 – one of two new coagulation analyzers from Transasia that provide users with freedom of testing choice from a broad range of tests and patients with dependable, timely results (Photos courtesy of Transasia Bio-Medicals).
The most common coagulation tests performed include PT, aPTT, and D Dimer. While in some labs there is a need for PT, aPTT, D Dimer, and fibrinogen, others such as (component separation) blood banks routinely perform fibrinogen and Factor VIII. Another customer set, specializing in coagulopathy, tests for certain rare parameters. However, not all available systems are equipped to cater to these requirements. Also in need of immediate attention are: not having small reagent pack sizes for D Dimer and unavailability of timely service in remote areas.

Towards resolution of these critical issues and catering to diverse customer needs, Transasia Bio-Medicals Ltd (Mumbai, India), launched two advanced coagulation analyzers: ERBA ECL 105 – Single Channel and ERBA ECL 412 – Four Channel. Both analyzers use an innovative technology thereby providing highly accurate and precise results at affordable cost.

Both instruments include the following key highlights and features: LCD touchscreen graphical display; built-in incubator for cuvette; facility for reagent incubation through magnetic stirring of reagents (especially beneficial for mixing silica or latex based reagents as they require constant stirring to maintain suspension of particulate matter); inbuilt robust thermal printer; Connectivity through USB ports, ethernet ports, and RFID detection facility; storage of data and coagulation clotting curves is possible on an external drive. The test menu includes comprehensive range of tests from clotting to chromogenic (only onECL 412) and immunologic tests; light scattering principle is used for performing assays - Clotting (640 nm), Chromogenic (405 nm), and D Dimer (800 nm). The software is user-friendly, with minimal, simple logical inputs in programming tests, multi-standard calibration, plotting multilevel quality control (QC) points, and running tests. It also includes proven technology of coagulation curve in percentage light scatter for clot detection.

The ERBA ECL 105/412 performs comprehensive coagulation tests in semiautomated systems. The tests (such as fibrinogen, factors assays, Lupus anticoagulant, AT III (only on ECL 412), Protein C, Protein S, and D Dimer) are programmed and can be performed with minimum effort. The QC plotting has been programmed keeping in mind the accreditation requirement of laboratory. Multilevel QC for each test is possible, a feature still rare in many single- and four-channel analyzers.

Related Links:

Transasia Bio-Medicals


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.